Director at Merit Medical Systems (MMSI) sells 5,000 shares

Rhea-AI Filing Summary

Merit Medical Systems director Lynne N. Ward reported an open-market sale of 5,000 shares of common stock on 2026-05-07. The weighted average sale price was $62.607 per share, from trades between $62.395 and $62.815. Ward now directly holds 7,809 shares.

Insider Trade Summary

Net Seller: 5,000 shares ($313,035)

Net Sell 1 txn

Insider Ward Lynne N.

Role null

Sold 5,000 shs ($313K)

Type	Security	Shares	Price	Value
Sale	Common Stock, No Par Value	5,000	$62.607	$313K

Holdings After Transaction: Common Stock, No Par Value — 7,809 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 5,000 shares Weighted average sale price: $62.607 per share Sale price range low: $62.395 per share +2 more

5 metrics

Shares sold 5,000 shares Open-market sale on May 7, 2026

Weighted average sale price $62.607 per share Price for 5,000 shares sold

Sale price range low $62.395 per share Lowest price within reported trade range

Sale price range high $62.815 per share Highest price within reported trade range

Shares held after transaction 7,809 shares Direct ownership following sale

Key Terms

open-market sale, weighted average price, Common Stock, No Par Value, Form 4

4 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average price financial

"The price reported in Column 4 of Table 1 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Common Stock, No Par Value financial

"security_title": "Common Stock, No Par Value""

Form 4 regulatory

"range set forth in this Form 4."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ward Lynne N.

(Last) (First) (Middle)

1600 WEST MERIT PARKWAY

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value	05/07/2026		S		5,000	D	$62.607(1)	7,809	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.395 to $62.815, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

	/s/ Brian G. Lloyd, Attorney-in-Fact	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Lynne N. Ward report at MMSI?

Director Lynne N. Ward reported selling 5,000 shares of Merit Medical Systems common stock in an open-market transaction. The sale used a weighted average price of $62.607 per share, with individual trades occurring between $62.395 and $62.815, and left her holding 7,809 shares.

At what price did the MMSI insider shares sell on May 7, 2026?

The reported weighted average sale price was $62.607 per share for the 5,000 MMSI shares sold. According to the disclosure, individual trades were executed in a price range between $62.395 and $62.815 per share, all on May 7, 2026, in open-market transactions.

How many Merit Medical (MMSI) shares does Lynne N. Ward hold after the sale?

After selling 5,000 shares, Lynne N. Ward directly holds 7,809 shares of Merit Medical Systems common stock. This remaining position is disclosed in the filing as the total shares beneficially owned following the reported open-market transaction on May 7, 2026.

Was the MMSI insider trade a buy or sell transaction?

The transaction was a sell. The Form 4 identifies a code "S" and describes it as an open-market sale, with 5,000 shares of Merit Medical Systems common stock sold at a weighted average price of $62.607 per share on May 7, 2026.

Did the MMSI Form 4 disclose a price range for the insider sale?

Yes. The filing states the price reported is a weighted average and that the 5,000 shares were sold in multiple trades at prices ranging from $62.395 to $62.815 per share. Full breakdown by price level is available upon request from the reporting person.